This application of the Comprehensive Cancer Center of Wake Forest University requests renewal of its Cancer Center Support Grant for Years 27 through 31. The Cancer Center has a clear and accessible organization with carefully enumerated priorities. In the past 1 + years, the CCCWFU has made substantial progress in scientific innovation and accomplishments: Key back science leadership positions have been filled, and 10 cancer-focused basic science faculty recruited. Research has been consolidated and strengthened into well-funded, cancer-focused programs. The research base off peer-reviewed cancer funding has increased from 5.5 to 9.7 million dollars. The Center has fostered the development of novel molecular approaches to cancer diagnosis and therapy, resulting in translational research linking our basic and clinical science programs. A new training grant in cancer biology has been approved for funding. The Center continues an outstanding record of community-based research in early detection, prevention and clinical trials, bolstered by an NCI Research Base Grant for Cancer Control and Therapy. Support is requested for four Programs: Cell Growth and Survival , DNA Damage and Cellular Defense, Clinical Research and Cancer Control and eight shared resources: Biostatistics, Clinical Research Management, Analytical Chemistry, Analytical Imaging, Biomolecular Resource Facility, Cell Culture and Viral Vector, Microscopy, and Tumor Tissue. A scientific strategy for the next five years has been carefully formulated. It includes the recruitment of more than 20 basic scientists in cancer research whose research target the Center's four Programs. More than 40,000 s.f. of cancer wet lab space are under construction to facilitate the research of these cancer investigators. The blueprint for this growth is embodied in this application, which provides the Center's vision of how it can reduce the burden of cancer in our region and in the nation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA012197-30
Application #
6801805
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1976-03-01
Project End
2006-01-31
Budget Start
2004-05-10
Budget End
2005-01-31
Support Year
30
Fiscal Year
2004
Total Cost
$1,321,779
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Melvin, Ryan L; Xiao, Jiajie; Godwin, Ryan C et al. (2018) Visualizing correlated motion with HDBSCAN clustering. Protein Sci 27:62-75
Faig, Jennifer; Haughton, Michael; Taylor, Richard C et al. (2018) Retrospective Analysis of Cisplatin Nephrotoxicity in Patients With Head and Neck Cancer Receiving Outpatient Treatment With Concurrent High-dose Cisplatin and Radiotherapy. Am J Clin Oncol 41:432-440
Nelson, Kimberly J; Perkins, Arden; Van Swearingen, Amanda E D et al. (2018) Experimentally Dissecting the Origins of Peroxiredoxin Catalysis. Antioxid Redox Signal 28:521-536
Swanner, Jessica; Singh, Ravi (2018) Synthesis, Purification, Characterization, and Imaging of Cy3-Functionalized Fluorescent Silver Nanoparticles in 2D and 3D Tumor Models. Methods Mol Biol 1790:209-218
Holmila, Reetta J; Vance, Stephen A; Chen, Xiaofei et al. (2018) Mitochondria-targeted Probes for Imaging Protein Sulfenylation. Sci Rep 8:6635
Feliz-Mosquea, Yismeilin R; Christensen, Ashley A; Wilson, Adam S et al. (2018) Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy. Breast Cancer Res Treat 172:69-82
Li, X C; Wang, M Y; Yang, M et al. (2018) A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma. Ann Oncol 29:938-944
Rego, Stephen L; Harvey, Scott; Simpson, Sean R et al. (2018) TREX1 D18N mice fail to process erythroblast DNA resulting in inflammation and dysfunctional erythropoiesis. Autoimmunity :1-12
Lu, Yong; Wang, Qiang; Xue, Gang et al. (2018) Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors. Cancer Cell 33:1048-1060.e7
Godwin, Ryan C; Macnamara, Lindsay M; Alexander, Rebecca W et al. (2018) Structure and Dynamics of tRNAMet Containing Core Substitutions. ACS Omega 3:10668-10678

Showing the most recent 10 out of 548 publications